









Mercado
/
Acciones
/
nasdaq-omcl
/

Omnicell Inc

OMCL

32.320USD

+0.060+0.19%

Cierre 09/16, 16:00（ET）Cotizaciones retrasadas 15 min

1.50BCap. mercado

64.98P/E TTM



Omnicell Inc

32.320

+0.060+0.19%

Descripción general Compañía Finanzas Análisis

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.

Información de la empresa

Símbolo de cotizaciónOMCL

Nombre de la empresaOmnicell Inc

Fecha de salida a bolsaAug 08, 2001

Director ejecutivoMr. Randall A. Lipps

Número de empleados3670

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 08

Dirección4220 North Freeway

CiudadFORT WORTH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited States of America

Código postal76137

Teléfono18774159990

Sitio Webhttps://www.omnicell.com/

Símbolo de cotizaciónOMCL

Fecha de salida a bolsaAug 08, 2001

Director ejecutivoMr. Randall A. Lipps

Ejecutivos de la empresa

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Randall A. Lipps

Chairman of the Board, President, Chief Executive Officer

428.14K

-1.93%

Mr. Nnamdi Njoku

Chief Operating Officer, Executive Vice President

90.93K

+69.90%

Mr. Robin Gene Seim

Independent Director

47.35K

+16.85%

Ms. Joanne B. Bauer

Lead Independent Director

44.90K

+18.74%

Mr. Bruce E. Scott

Independent Director

22.97K

+42.59%

Mr. Corey J. Manley

Executive Vice President, Chief Legal and Administrative Officer

18.48K

-13.13%

Mr. Edward Peter Bousa

Independent Director

17.99K

+56.40%

Ms. Mary Garrett

Independent Director

17.18K

+70.20%

Mr. Kaushik (Bobby) Ghoshal

Independent Director

14.52K

+78.84%

Mr. Baird Radford

Chief Financial Officer, Executive Vice President

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Randall A. Lipps

Chairman of the Board, President, Chief Executive Officer

428.14K

-1.93%

Mr. Nnamdi Njoku

Chief Operating Officer, Executive Vice President

90.93K

+69.90%

Mr. Robin Gene Seim

Independent Director

47.35K

+16.85%

Ms. Joanne B. Bauer

Lead Independent Director

44.90K

+18.74%

Mr. Bruce E. Scott

Independent Director

22.97K

+42.59%

Mr. Corey J. Manley

Executive Vice President, Chief Legal and Administrative Officer

18.48K

-13.13%

Desglose de ingresos

Divisa: USDActualizado: dom., 6 de jul

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Connected devices, software licenses, and other

120.08M

44.53%

SaaS and Expert Services

63.12M

23.41%

Technical services

61.38M

22.76%

Consumables

25.09M

9.30%

Por regiónUSD

Nombre

Ganancia

Proporción

United States

249.26M

92.43%

Rest of the World

20.40M

7.57%

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Connected devices, software licenses, and other

120.08M

44.53%

SaaS and Expert Services

63.12M

23.41%

Technical services

61.38M

22.76%

Consumables

25.09M

9.30%

Estadísticas de accionistas

Actualizado: vie., 15 de ago

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

14.84%

The Vanguard Group, Inc.

12.23%

Dimensional Fund Advisors, L.P.

4.72%

State Street Global Advisors (US)

4.56%

Lazard Asset Management, L.L.C.

3.72%

Otro

59.94%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

14.84%

The Vanguard Group, Inc.

12.23%

Dimensional Fund Advisors, L.P.

4.72%

State Street Global Advisors (US)

4.56%

Lazard Asset Management, L.L.C.

3.72%

Otro

59.94%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

48.12%

Investment Advisor/Hedge Fund

36.85%

Hedge Fund

13.77%

Research Firm

3.15%

Individual Investor

1.88%

Sovereign Wealth Fund

1.51%

Pension Fund

1.36%

Bank and Trust

0.94%

Family Office

0.05%

Participación institucional

Actualizado: mar., 1 de jul

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q2

681

49.10M

106.89%

-9.34M

2025Q1

708

50.20M

107.17%

-8.54M

2024Q4

716

48.64M

104.03%

-9.20M

2024Q3

742

47.70M

103.68%

-13.09M

2024Q2

766

48.23M

105.00%

-10.57M

2024Q1

786

47.95M

104.43%

-7.71M

2023Q4

812

47.51M

104.50%

-6.33M

2023Q3

817

49.57M

109.64%

-4.16M

2023Q2

820

48.12M

106.76%

-6.53M

2023Q1

823

48.10M

106.74%

-4.33M

Actividad de los accionistas

Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

6.94M

14.81%

-199.83K

-2.80%

Mar 31, 2025

The Vanguard Group, Inc.

5.56M

11.88%

+11.69K

+0.21%

Mar 31, 2025

Dimensional Fund Advisors, L.P.

1.88M

4.02%

+241.88K

+14.73%

Mar 31, 2025

State Street Global Advisors (US)

2.17M

4.62%

-79.02K

-3.52%

Mar 31, 2025

Lazard Asset Management, L.L.C.

1.65M

3.51%

+3.79K

+0.23%

Mar 31, 2025

Amova Asset Management Co., Ltd.

1.41M

-44.49K

-3.07%

Mar 31, 2025

D. E. Shaw & Co., L.P.

1.40M

2.98%

+455.16K

+48.39%

Mar 31, 2025

Victory Capital Management Inc.

1.68M

3.59%

+154.04K

+10.09%

Mar 31, 2025

Macquarie Investment Management

1.14M

2.44%

+27.97K

+2.51%

Mar 31, 2025

ETFs relacionados

Actualizado: sáb., 6 de sep

Nombre

Proporción

SPDR S&P Health Care Equipment ETF

2.03%

Global X HealthTech ETF

1.43%

Invesco S&P SmallCap Health Care ETF

1.15%

ROBO Global Healthcare Technology & Innovation ETF

1.14%

Global X Robotics & Artificial Intelligence ETF

0.58%

First Trust Nasdaq AI and Robotics ETF

0.45%

ETC 6 Meridian Low Beta Equity Strategy ETF

0.36%

Fidelity Enhanced Small Cap ETF

0.31%

SPDR S&P Kensho New Economies Composite ETF

0.28%

First Trust Small Cap Value AlphaDEX Fund

0.28%

SPDR S&P Health Care Equipment ETF

Proporción2.03%

Global X HealthTech ETF

Proporción1.43%

Invesco S&P SmallCap Health Care ETF

Proporción1.15%

ROBO Global Healthcare Technology & Innovation ETF

Proporción1.14%

Global X Robotics & Artificial Intelligence ETF

Proporción0.58%

First Trust Nasdaq AI and Robotics ETF

Proporción0.45%

ETC 6 Meridian Low Beta Equity Strategy ETF

Proporción0.36%

Fidelity Enhanced Small Cap ETF

Proporción0.31%

SPDR S&P Kensho New Economies Composite ETF

Proporción0.28%

First Trust Small Cap Value AlphaDEX Fund

Proporción0.28%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones

Fecha

Tipo

Relación

Sin datos

Fecha

Tipo

Relación

Sin datos

KeyAI

